首页> 外文期刊>Oncology, Gastroenterology and Hepatology Reports >To Assess the Efficacy and Safety of Various Anti-heliminthics against Ascariasis Lumbricoides among a Study Population in North India
【24h】

To Assess the Efficacy and Safety of Various Anti-heliminthics against Ascariasis Lumbricoides among a Study Population in North India

机译:在印度北部的研究人群中评估各种抗he药抗against虫病的功效和安全性

获取原文
       

摘要

Introduction: More than 24% of the world’s population, are infected with soil-transmitted helminth infection. Aim: To assess the helminthic load & efficacy and safety of various antiheliminthics. Methods: A total of 400 patients who met the inclusion criteria were recruited after proper consent. Subjects were divided into Four groups (100 each) randomly & receive different anti- helminthic drugs. Cure rate and egg reduction rate was used as a primary outcome measure. Three weeks later two more stool samples were analyzed by two methods 1) Direct Smear method & 2) Concentration method. On follow-up, each group were randomly assigned a single dose of albendazole (single 400 mg dose), mebendazole (100 mg, BD×3 days), pyrantel pamoate (11 mg/kg orally once) and ivermectin (0.2 mg/kg orally once) using a randomization procedure.The data was statistically analysed. Observations: Among 400 patients, 63% were 5-19 years of age, 68% were male, 73.5% were from rural areas, 71% were literate, 62% were in the low income group, 58% reported closed sanitation, 6.75% were having low BMI, 26.25% were having High Absolute Eosinophilic Count before treatment, 77.5% were non-anaemic. 92.5% did not have icterus. In the present study it was seen that the difference among the four drugs was statistically significant as per demographic variables. Significant decrease of worm load after treatment were comparable with each other. However, Presence of Worm across papillae seen after upper GI endoscopy and persistent biliary ascariasis was comparable in all the four drug groups. Overall, the efficacy of anthelmintic drugs was excellent and statistically significant ( p 0.001). Conclusion: Albendazole and mebendazole having cure rates of 90% and also reducing the mean egg count by 90%. Also treatment of school children every 4 monthly may be necessary in high endemic areas, like ours. All these drugs which we used in our study are safe and no significant side effects were observed.
机译:简介:世界上超过24%的人口感染了土壤传播的蠕虫感染。目的:评估各种抗蠕虫药的蠕虫负荷,功效和安全性。方法:经过适当同意,共招募了符合入选标准的400名患者。将受试者随机分为四组(每组100个)并接受不同的抗蠕虫药。治愈率和减蛋率用作主要结局指标。三周后,通过两种方法(1)直接涂片法和2)浓缩法分析了另外两个粪便样品。随访时,每组随机分配单剂量的阿苯达唑(400毫克单次),甲苯咪唑(100毫克,BD×3天),吡咯烷酸酯(11毫克/千克口服一次)和伊维菌素(0.2毫克/千克)口服一次)。对数据进行统计分析。观察结果:在400名患者中,年龄在5-19岁之间的患者为63%,男性为68%,农村地区为73.5%,有文化的为71%,低收入人群为62%,封闭卫生的患者为58%,6.75% BMI较低,治疗前绝对嗜酸细胞计数高的占26.25%,非贫血的占77.5%。 92.5%没有黄疸。在本研究中,根据人口统计学变量,发现四种药物之间的差异具有统计学意义。处理后蠕虫负荷的显着降低彼此相当。但是,在所有四个药物组中,上消化道内窥镜检查和持续性胆管as虫病后发现的乳头间蠕虫的存在是可比的。总体而言,驱虫药的疗效极佳且具有统计学意义(p <0.001)。结论:阿苯达唑和甲苯达唑治愈率达90%,平均卵数减少了90%。在像我们这样的高流行地区,也有必要每4个月对小学生进行一次治疗。我们在研究中使用的所有这些药物都是安全的,没有观察到明显的副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号